BSECompany Update3d ago · 3 Aug 2026, 10:30 pm
Monitoring Agency Report for the quarter ended June 30, 2026.
Nazara Technologies Ltd · 543280
✦ AI SummaryResults
Nazara Technologies Ltd has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as required by SEBI regulations, detailing the utilization of proceeds from a preferential issue of equity shares.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Nazara Technologies Ltd - 543280 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Attachments (1)
📄pdf
Download →
47c4bbf4-2c03-4a64-b41a-1b0de5346d18.pdf
View document text
August 03, 2026
Listing Compliance Department Listing Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block,
Dalal Street, Bandra -Kurla Complex, Bandra (East),
Mumbai - 400 001. Mumbai- 400051.
Scrip Code: 543280 Scrip Symbol: NAZARA
Dear Sir/Madam,
Subject: Monitoring Agency Report for the quarter ended on June 30, 2026
With reference to the above subject, pursuant to Regulation 32(6) of the Securities and Exchange Board
of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with
Regulation 162A of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as
amended (“SEBI ICDR Regulations”), we are enclosing the Monitoring Agency Report of the
Company for the quarter ended June 30, 2026, issued by ICRA Limited, the Monitoring Agency,
appointed by the Company to monitor the utilisation of proceeds raised through the issuance and
allotment of 50,00,000 fully paid up Equity Shares of the Company having face value of INR 4/- each
at a price of INR 990/- (including a premium of INR 986/-) per equity share, by way of Preferential
Issue under Chapter V of SEBI ICDR Regulations.
You are requested to take the same on record.
Thanking you.
Yours faithfully,
For Nazara Technologies Limited
Arun Bhandari
Company Secretary and Compliance Officer
Encl. As above
ICRA Limited
Date: August 03, 2026
Mr. Rakesh Shah
Chief Financial Officer
Nazara Technologies Limited
11th Floor Avighna House,
Dr Annie Besant Road,
Worli Naka Mumbai – 400018
Dear Sir,
Re: Final Monitoring Agency report of Nazara Technologies Limited for Q1 FY2027
Please refer to agreement dated January 29, 2025, appointing ICRA Limited as the Monitoring Agency (MA) for
Nazara Technologies Limited’s Preferential Issue.
After due consideration, ICRA has prepared the attached final Monitoring Agency report as per SEBI (Issue of
Capital and Disclosure Requirements) Regulations for Q1 FY2027.
Please note that the Monitoring Agency report does not constitute a commentary on the quality of the objects of
the issue, appropriateness or reasonableness of costs or spending by Nazara Technologies Limited against any
objects / heads or assurance on outcome of such spending.
We thank you for your kind cooperation extended during the course of Q1 FY2027. Should you require any
clarification, please do not hesitate to get in touch with us.
We look forward to your communication and assure you of our best services.
With kind regards
For ICRA Limited
Parul Goyal Narang
Vice President & Head- Process Excellence
Parul.goyal@icraindia.com
Building No. 8, 2nd Floor, Tower A Tel.: +91.124 .4545300 Website: www.icra.in
DLF Cyber City, Phase II CIN : L749999DL1991PLC042749 Email: info@icraindia.com
Gurugram – 122002, Haryana Helpdesk: +91 9354738909
Registered Office: B-710, Statesman House, 148, Barakhamba Road, New Delhi 110001. Tel. :+91.11.23357940-41
RATING ● RESEARCH ● INFORMATION
Sensitivity Label : Confidential
June 2026
MONITORING AGENCY REPORT FORMAT
Name of the Issuer: Nazara Technologies Limited
For the Quarter ended: June 30, 2026.
Name of the Monitoring Agency (MA): ICRA Limited
(a) Deviation from the objects of the issue:
No deviation - the utilization of the issuance proceeds is in line with the objects of the issue.
(b) Range of deviation:
No deviation
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the
issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate
and reliable. The MA does not perform an audit and undertakes no independent verification of any information/
certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which
accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions
expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing
mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any
issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined
under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial
transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain
creditrelated analyses. We confirm that we do not perceive any conflict of interest in such relationship/ interest while
monitoring and reporting the utilization of the issue proceeds by the issuer. We have submitted the report herewith in line
with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under
the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the
Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through
stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments
of the issuer’s Management/Board.
Signature:
Parul Goyal Narang
Vice President & Head- Process Excellence
Analyst: Subhechha Banerjee
Quality Analyst: Parul Narang
Sensitivity Label : Confidential
June 2026
1. Issuer Details
Name of the Issuer: Nazara Technologies Limited
Name(s) of the promoter:
Promoters
Nitish Mittersain
Vikash Mittersain
Mitter Infotech LLP
Plutus Wealth Management LLP
Axana Estates LLP
Source: BSE
Industry/ sector to which it belongs:
- Software.
2. Issue Details
Issue Period: Opening Date: NA
Closing Date: NA
Type of Issue: Preferential Issue
Type of specified securities: Preferential issue of Equity Shares
IPO Grading, if any: Not Applicable
Issue Size (Rs. Crore): Issue Size: INR 495.00 crores (50,00,000 fully paid-up Equity Shares of INR 990.00 each including
premium of INR 986.00 each)
With OFS portion: Not Applicable.
Excluding OFS portion: Not Applicable
Gross Proceeds: INR 495.00 Crore.
Note: Issue related expenses incurred till Q1FY27 are INR 0.38 Crore. ICRA will be monitoring the Proceeds of INR 495.00
Crore.
Sensitivity Label : Confidential
June 2026
3. Details of the arrangement made to ensure the monitoring of issue proceeds
Source of information, Comments of
certifications considered by Comments of the Monitoring the Issuer’s
Particulars Reply
the Monitoring Agency for Agency Board of
the preparation of report Directors
-Peer reviewed CA Certificate
-Confirmation from
Whether all utilization is as per management
the disclosures in the Offer Yes -Bank Statement No deviation observed
Document? -Offer Letter
-Notice of EOGM held on
February 13, 2025
Whether shareholder approval
has been obtained in case of
Not As confirmed by the Issuer’s
material deviations# from No comments
Applicable management
expenditures disclosed in the
Offer Document?
Whether the means of finance
As confirmed by the Issuer’s
for the disclosed objects of the No No comments
management
issue has changed?
Is there any major deviation
observed over the earlier No No deviation observed No comments
monitoring agency reports?
Whether all Government/
statutory approvals related to Not As confirmed by the Issuer’s
No comments
the object(s) have been Applicable management
obtained?
Whether all arrangements
pertaining to technical Not As confirmed by the Issuer’s
No comments
assistance/ collaboration are in Applicable management
operation?
Are there any favorable events
As confirmed by the Issuer’s As understood from the
improving the viability of these No
management Issuer’s management
object(s)?
Are there any unfavorable
As confirmed by the Issuer’s As understood from the
events affectin
[Showing first 8,000 characters — download PDF for full document]